Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles
试验速览
- 阶段
- 不适用
- 试验地点
- 1
- 主要终点
- pregnancy and delivery rates
研究概览
简要总结
Supraphysiological hormonal stimulation enables collecting many oocytes in an In-Vitro Fertilization treatment, but may have a negative effect on uterine function and contribute the fact that the majority of preembryos placed in the uterus fail to implant.
Several medical agents were shown to be beneficial when given in the luteal phase of an IVF cycle, but the optimal regimen has not been yet determined. In 2006, a European group reported that addition of GnRH analog (Decapeptyl) as luteal support in IVF cycle significantly improved pregnancy and delivery rates. It is not known whether this positive effect influences the corpus luteum, embryo or the uterus. The researchers sought to evaluate the effect of GnRH administration as luteal support in frozen-thaws IVF cycle.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 38 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •IVF patients transfer of a minimum of two medium-quality thawed embryos in IVF
排除标准
- •Two or more fresh IVF embryo transfer or three or more thawed embryos transfer with no pregnancy.
- •maximal endometrial thickness < 6 mm or intracavitary fluid at the time of embryo transfer on previous cycles
- •Untreated hydrosalpinges
- •intracavitary mass
- •submucous myoma
- •known allergy to one of medical agents used in the study
研究组 & 干预措施
1
GnRH analog administration following embryo transfer
干预措施: Decapeptyl 0.1 mg after embryo transfer (Drug)
结局指标
主要结局
pregnancy and delivery rates
次要结局
未报告次要终点
